Transcatheter closure of patent ductus arteriosus in infants weighing less than 6 kilograms – a two-center experience. Technical considerations
Cardiology Journal · 2025
DOI: 10.5603/cj.102639 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cardiology Journal, 2025. Verfasst von Michał Gałeczka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Cardiology and Congenital Heart Defects, FMS in Zabrze, Medical University of Silesia in Katowice, Silesian Center for Heart…. Hauptthemen laut MEDLINE: Ductus Arteriosus, Patent, Cardiac Catheterization, Septal Occluder Device. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Transcatheter closure has become the method of choice for treating patent ductus arteriosus (PDA) in a majority of patients. The only approved device for treating infants weighing less than 6 kilograms is the Amplatzer Piccolo Occluder (APO). The aim of this study is to summarize the experience of two centers in performing transcatheter PDA closure in infants weighing less than 6 kilograms. METHODS: Retrospective, descriptive, and nonrandomized analysis included all 45 infants weighing less than 6 kg who underwent transcatheter PDA closure between 2013 and 2023 at two tertiary centers, following the introduction of APO. Medical records, procedural outcomes, and one-month follow-up were analyzed. Applied devices were: APO in 37 (of whom 3 were off-label due to PDA size), Amplatzer Duct Occluder I (ADO) in 3, and Amplatzer Vascular Plug II (AVP) in 5 cases. RESULTS: The overall success rate was 97.8%. There were 2 major complications (4.4%), including one device protrusion. A residual shunt was noted in one patient 24 hours after the procedure, but none were observed after one month. Off-label devices were implanted in insignificantly larger and longer PDAs. There were no significant differences between the labeled and off-label groups in terms of procedural success, major complications, or residual shunts. CONCLUSIONS: APO is a safe and effective device to treat PDA in infants weighing less than 6 kilograms, however, off-label devices are needed in a considerable number of patients. Proper use of off-label devices yields comparable to APO results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatric Cardiology and Congenital Heart Defects, FMS in Zabrze, Medical University of Silesia in Katowice, Silesian Center for Heart Diseases, Zabrze, Poland. michalgaleczka@gmail.com.
- Student Scientific Association at Department of Paediatric Cardiology and Congenital Heart Defects, FMS in Zabrze, Medical University of Silesia in Katowice, Poland.
- Department of Paediatric Cardiac Surgery, St. Adalbertus Hospital, Gdansk-Zaspa, Poland.
- Department of Paediatric Cardiology and Congenital Heart Defects, FMS in Zabrze, Medical University of Silesia in Katowice, Silesian Center for Heart Diseases, Zabrze, Poland.
ORCID-Profile: Michał Gałeczka, Filip Tyc, Roland Fiszer
Zitieren
APA
Gałeczka, M., Kapałka, M., Chojnicki, M., Krawiec, M., Tyc, F., & Fiszer, R. (2025). Transcatheter closure of patent ductus arteriosus in infants weighing less than 6 kilograms – a two-center experience. Technical considerations. Cardiology Journal. https://doi.org/10.5603/cj.102639
Vancouver
Gałeczka M, Kapałka M, Chojnicki M, Krawiec M, Tyc F, Fiszer R. Transcatheter closure of patent ductus arteriosus in infants weighing less than 6 kilograms – a two-center experience. Technical considerations. Cardiology Journal. 2025. doi:10.5603/cj.102639
BibTeX
@article{Gaeczka2025,
author = {Gałeczka, Michał and Kapałka, Michał and Chojnicki, Maciej and Krawiec, Michał and Tyc, Filip and Fiszer, Roland},
title = {Transcatheter closure of patent ductus arteriosus in infants weighing less than 6 kilograms – a two-center experience. Technical considerations},
journal = {Cardiology Journal},
year = {2025},
doi = {10.5603/cj.102639}
}
EUVIMED